Bristol Myers Squibb Sells Convatec - A Strategic Shift In Focus To Biopharmaceuticals

London, United Kingdom (PressExposure) December 28, 2009 -- A New York -based private equity firm Avista and Stockholm-based Nordic Capital Fund VII has agreed to acquire Convatec, Princeton, N.J, a manufacturer and marketer of ostomy and modern wound and skin care products, from New York-based biopharmaceutical and health-care company Bristol-Myers Squibb for $4.1 billion. The transaction is expected to be completed in the third quarter of 2008.

The global advanced wound care management market was valued at $1.73 billion in 2007. The advanced wound management market showed high growth rates historically, a trend that is expected to continue in the future. The rapid growth in this market can be attributed to advanced wound care replacing the traditional wound care market. The global ostomy market, valued at $1.7 billion in 2007 grew at a CAGR of 5.6 percent in last five years.

This analysis was taken from a research paper published by GlobalData, to download the full Research Paper for free, click below:

Access the latest Wound Care Management analysis for free at


ResearchViews is your number one portal for industry related news, research, analysis and deals data. ResearchViews offers up to the minute content produced by an expert team of industry analysts.

All content on the site is free to view and allows users to keep up to date with the latest developments in their chosen industry. Free daily and weekly newsletters provide a snapshot of the major issues affecting the industry. The site also features a research store, providing the user with access to premium business intelligence from some of the world's leading market research publishers.

About GlobalData

GlobalData is a global market intelligence services company providing information research and analysis products and services.

Press Release Source:

Press Release Submitted On: December 28, 2009 at 5:30 am
This article has been viewed 20724 time(s).